| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84826 |
DOTA-ST8950 DOTA偶联碘代氨基酸的类似物ST8950 |
167 |
h |
2024-12-19 |
| 84827 |
DOTA官能化酞菁纳米点 DOTA‐Functionalized Phthalocyanine Nanodots |
150 |
h |
2024-12-19 |
| 84828 |
DOTA-D-Phe1-Tyr3-octreotide preparations |
117 |
h |
2024-12-19 |
| 84829 |
DOTA-4Py 螯合剂DOTA偶联吡啶基4Py |
119 |
h |
2024-12-19 |
| 84830 |
钆喷酸葡胺(Gd-BOPTA) |
323 |
h |
2024-12-19 |
| 84831 |
DOTA-SA-mAb |
145 |
h |
2024-12-19 |
| 84832 |
(LLP2A-DOTA)(4)PEG(10000) |
146 |
h |
2024-12-19 |
| 84833 |
LLP2A-DOTA-聚乙二醇 LLP2A-DOTA-PEG |
135 |
h |
2024-12-19 |
| 84834 |
DOTA-AaLS/HER2Afb HER2Afb修饰DOTA缀合的AaLS-ST |
155 |
h |
2024-12-19 |
| 84835 |
DOTA-P4 Thz-Phe-D-Trp-Lys-Thr-DOTA DOTA的线型超短肽缀合物 |
162 |
h |
2024-12-19 |
| 84836 |
DOTA-BP DOTA偶联双膦酸盐 |
211 |
h |
2024-12-19 |
| 84837 |
DOTA缀合的p160肽基放射缀合物 DOTA-p160 |
167 |
h |
2024-12-19 |
| 84838 |
DOTA-氮氧化合物 DOTA-NOx |
157 |
h |
2024-12-19 |
| 84839 |
Er-DOTA 铒-DOTA配合物 |
207 |
h |
2024-12-19 |
| 84840 |
DOTA-SETSKSF DOTA偶联七个氨基酸残基组成的环肽抑制剂 |
218 |
h |
2024-12-19 |
| 84841 |
羧基Bn-DOTA p-COOH-Bn-DOTA |
167 |
h |
2024-12-19 |
| 84842 |
DOTA四酰肼钆(ⅲ)配合物 |
151 |
h |
2024-12-19 |
| 84843 |
3-Gd(III)-氨基乙基酰胺基-DOTA的缀合物 |
166 |
h |
2024-12-19 |
| 84844 |
TCO功能化的CC49抗体 TCO-CC49 |
489 |
h |
2024-12-19 |
| 84845 |
CLT1肽靶向Gd(III)螯合物 CLT1-dL-(Gd-DOTA) |
265 |
h |
2024-12-19 |
| 84846 |
DOTA-pNO(2)-Phe-c(DCys-Tyr-DTrp-Lys-Thr-Cys)DTyrNH |
242 |
h |
2024-12-19 |
| 84847 |
Gd-DOTA-PLGA-b-PEG 钆-四氮杂环十二烷四乙酸共轭的聚(乳酸-共-乙醇酸)-嵌段-聚(乙二醇)共聚物胶束 |
219 |
h |
2024-12-19 |
| 84848 |
DOTA聚乙二醇化星形共聚物纳米粒子 |
147 |
h |
2024-12-19 |
| 84849 |
镓-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-Leu-Thr-Val-Ser-Pro-Trp-Tyr |
177 |
h |
2024-12-19 |
| 84850 |
DOTA-C595 p-SCN-Bn-DOTA偶联C595抗体 |
232 |
h |
2024-12-19 |
| 84851 |
DOTA-Tyr3-奥曲肽 DOTA-Tyr3-TOC |
184 |
h |
2024-12-19 |
| 84852 |
DOTA-生物素-亲和素 DOTA-biotin-avidin |
147 |
h |
2024-12-19 |
| 84853 |
DOTA-AuNPs 螯合剂DOTA包覆金纳米颗粒 |
171 |
h |
2024-12-19 |
| 84854 |
PS-WSCS-DOTA-BBN 水溶性壳聚糖缀合的DOTA-铃蟾肽包覆的金纳米颗粒 |
168 |
h |
2024-12-19 |
| 84855 |
苄基DOTA Bn-DOTA |
340 |
h |
2024-12-19 |
| 84856 |
DOTA-LM3 生长抑素受体(SSTR)拮抗剂 |
187 |
h |
2024-12-19 |
| 84857 |
Ga-DOTA-MGS5 大环配体-靶向肽 |
158 |
h |
2024-12-19 |
| 84858 |
Re-cyc-DOTA-sst2-ANT复合物 |
157 |
h |
2024-12-19 |
| 84859 |
DOTA-SP DOTA-P物质(SP) |
192 |
h |
2024-12-19 |
| 84860 |
DOTA-MG45 DOTA偶联迷你胃泌素(MG45) |
166 |
h |
2024-12-19 |
| 84861 |
DOTA-甘露糖胺葡聚糖 DOTA-MADs |
140 |
h |
2024-12-19 |
| 84862 |
ICG-DOTA 大环配体DOTA修饰吲哚菁绿荧光染料 |
168 |
h |
2024-12-18 |
| 84863 |
DOTA-SSA 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)-生长抑素类似物(SSA) |
150 |
h |
2024-12-18 |
| 84864 |
DOTA螯合剂修饰[cPP(1-7) |
224 |
h |
2024-12-18 |
| 84865 |
DOTA-ALB-24 DOTA-4-(对碘苯基)丁酸酯-24 |
157 |
h |
2024-12-18 |
| 84866 |
DOTA-GGNle-CycMSH hex DOTA偶联新肽 |
172 |
h |
2024-12-18 |
| 84867 |
Zr-p-NO2Bn-DOTA异构体 锆-硝基苄基偶联DOTA螯合剂 |
183 |
h |
2024-12-18 |
| 84868 |
DOTA-PSMA-617 1,4,7,10-四氮杂环十五烷偶联PSMA-617 |
151 |
h |
2024-12-18 |
| 84869 |
DOTA-VAP-1 螯合剂DOTA偶联VAP-1靶向肽 |
329 |
h |
2024-12-18 |
| 84870 |
DOTA-GIP-C803 DOTA螯合剂缀合GIPC803肽 |
140 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询